eda Estudios de Administración Estud. adm. (En línea) 0717-0653 0719-0816 Universidad de Chile. Facultad de Economía y Negocios. Departamento de Administración 10.5354/0719-0816.2021.59650 Artículos Responsabilidad Social Empresarial en la industria farmacéutica Corporate Social Responsibility in the pharmaceutical industry Mejia Reatiga Camilo Antonio 1 Gonzalez Barranco Saul Enrique 1 Torres-Saumeth Katherine María 2 Escuela de Negocios, Universidad del Norte Escuela de Negocios, Universidad del Norte Escuela de Negocios, Universidad del Norte Colombia cmejia@uninorte.edu.co sgonzale@uninorte.edu.co Facultad de Química y Farmacia, Universidad del Atlántico Facultad de Química y Farmacia, Universidad del Atlántico Facultad de Química y Farmacia, Universidad del Atlántico Colombia katherinetorres@mail.uniatlantico.edu.co Jan-June 2021 28 1 32 60 06 11 2020 12 04 2021 Este es un artículo publicado en acceso abierto bajo una licencia Creative Commons Resumen:

El objetivo principal de este artículo es conocer entre otros aspectos, las temáticas estudiadas, tipos de investigaciones realizadas y evidenciar gaps para el desarrollo de investigaciones futuras con respecto a la Responsabilidad Social Empresarial (RSE) en la Industria Farmacéutica. Para ello, se llevó a cabo una revisión del estado de las investigaciones en la temática, publicadas en el período 2000-2020 en las revistas con mayor índice de impacto según el Journal Citation Report (JCR) mediante búsqueda en Web of Science. Asimismo, se presentan posibles razones por las cuales las organizaciones se involucran en la RSE; el planteamiento de diferentes definiciones del concepto y la exposición de argumentos para lograr un acercamiento a su comprensión en el marco de la industria farmacéutica; además, se plantean aspectos sobre la necesidad de la integración de la RSE, que son característicos de la naturaleza de este tipo de industria. Entre las principales conclusiones se plantea la superficialidad con la que aún se enfrenta la industria con respecto a la RSE, la necesidad de involucrar a terceros como el Estado y temas conexos como el papel del consumidor o la internacionalización de las compañías farmacéuticas.

 Abstract:

What lies ahead in the research into Corporate Social Responsibility (CSR) in the Pharmaceutical Industry? This article analyzes the topics now being studied, the types of research already undertaken and obvious gaps that have to be filled for its development. To this end, we reviewed the investigations conducted in the 2000-2020 period in the highest-impact journals (according to Journal Citation Report - JCR), through a search in Web of Science. There are various reasons for organizations to formally assume CSR; there are several definitions of the concept and there are different ways to understand it within the environment of the Pharmaceutical Industry. The need to incorporate CSR strategies and programs designed for this type of industry is generally accepted, nevertheless, the main conclusions are unfortunately that the industry still shows a superficial attitude to CSR, and on the other hand that third parties such as the State will have to become involved. The role of the consumer and the internationalization of pharmaceutical companies are also of paramount importance.

 Palabras clave: Responsabilidad Social Empresarial Industria Farmacéutica Partes Interesadas Keywords: Corporate Social Responsibility Pharmaceutical Industry Stakeholders

Full text available only in PDF format.

Texto completo disponible sólo en PDF.

Declaración de conflicto de interés

Los autores del presente manuscrito manifiestan que no existen conflictos de interés con ninguna entidad o institución, ni de carácter personal en esta publicación.

 Referencias bibliográficas Abraham, J.(2002). "The pharmaceutical industry as a political player". The Lancet. 360 (9344), 1498-1502. Recuperado de https://doi.org/10.1016/s0140-6736(02)11477-2 Abraham J. 2002 The pharmaceutical industry as a political player The Lancet 360 9344 1498 1502 https://doi.org/10.1016/s0140-6736(02)11477-2" Ahen, F. (2017). Responsibilization and MNC-stakeholder engagement: Who engages whom in the pharmaceutical industry? . En Freeman, R., Kuhala, J., Sachs, S (autor.);Stakeholder engagement: Clinical research cases. (87-112).: Springer Recuperado de https://doi.org/10.1007/978-3-319-62785-4_5 Ahen F. Responsibilization and MNC-stakeholder engagement: Who engages whom in the pharmaceutical industry? 2017 Stakeholder engagement: Clinical research cases Springer 87 112 https://doi.org/10.1007/978-3-319-62785-4_5" Álvarez, C., Urbano, D.(2011). "Una década de investigación basada en el GEM: Logros y retos (A decade of GEM research: Achievements and challenges)". Academia Revista Latinoamericana de Administración. 46 , 16-37. Recuperado de https://ssrn.com/abstract=1801167 Álvarez C. Urbano D. 2011 Una década de investigación basada en el GEM: Logros y retos (A decade of GEM research: Achievements and challenges) Academia Revista Latinoamericana de Administración 46 16 37 https://ssrn.com/abstract=1801167" Becchetti, L., Ciciretti, R., Hasan, I., Kobeissi, N.(2012). "Corporate social responsibility and shareholder’s value". Journal of Business Research. 65 (11), 1628-1635. Recuperado de https://doi.org/10.1016/j.jbusres.2011.10.022 Becchetti L. Ciciretti R. Hasan I. Kobeissi N. 2012 Corporate social responsibility and shareholder’s value Journal of Business Research 65 11 1628 1635 https://doi.org/10.1016/j.jbusres.2011.10.022" Benn, S., Todd, L., Pendleton, J.(2010). "Public relations leadership in corporate social responsibility". Journal of Business Ethics. 96 (3), 403-423. Recuperado de https://doi.org/10.1007/s10551-010-0474-5 Benn S. Todd L. Pendleton J. 2010 Public relations leadership in corporate social responsibility Journal of Business Ethics 96 3 403 423 https://doi.org/10.1007/s10551-010-0474-5" Boulouta, I., Pitelis, C.(2014). "Who needs CSR? The impact of corporate social responsibility on national competitiveness". Journal of Business Ethics. 119 (3), 349-364. Recuperado de https://doi.org/10.1007/s10551-013-1633-2 Boulouta I. Pitelis C. N. 2014 Who needs CSR? The impact of corporate social responsibility on national competitiveness Journal of Business Ethics 119 3 349 364 https://doi.org/10.1007/s10551-013-1633-2" Bowen, H., (1953). Social responsibilities of the businessman (1st ed.). . : Harper & Brothers Bowen H. R. 1953 Social responsibilities of the businessman (1st ed.). Harper & Brothers Carroll, A.(1979). "A three-dimensional conceptual model of corporate performance". Academy of Management Review. 4 (4), 497-505. Recuperado de https://doi.org/10.2307/257850 Carroll A. B. 1979 A three-dimensional conceptual model of corporate performance Academy of Management Review 4 4 497 505 https://doi.org/10.2307/257850" Class, J.(2012). "Emerging markets and differential pricing policies: A question of global health?". Journal of Commercial Biotechnology. 18 (4), 40-43. Class J. 2012 Emerging markets and differential pricing policies: A question of global health? Journal of Commercial Biotechnology 18 4 40 43 Chan, W., Cheah, J., Montanheiro, L. (2016). Corporate social responsibility in the pharmaceutical industry . En Örtenblad, A (autor.);Research handbook on corporate social responsibility in context. (1st ed). (175-204).: Edward Elgar Publishing Limited Recuperado de https://doi.org/10.4337/9781783474806 Chan W. Cheah J. Montanheiro L. Corporate social responsibility in the pharmaceutical industry 2016 Research handbook on corporate social responsibility in context. (1st ed) Edward Elgar Publishing Limited 175 204 https://doi.org/10.4337/9781783474806" Cheah, E., Chan, W., Chieng, C.(2007). "The corporate social responsibility of pharmaceutical product recalls: An empirical examination of U.S. and U.K. markets.". Journal of Business Ethics. 76 (4), 427-449. Recuperado de https://doi.org/10.1007/s10551-006-9292-1 Cheah E. T. Chan W. L. Chieng C. L. L. 2007 The corporate social responsibility of pharmaceutical product recalls: An empirical examination of U.S. and U.K. markets. Journal of Business Ethics 76 4 427 449 https://doi.org/10.1007/s10551-006-9292-1" Commission des Communautés Européennes (C.C.E.) 2001. Livre vert. Protnotivoir un cadre eut opeen pour la responsabilité sociale des enterprises. (C.C.E.). Recuperado de https://europarl. europa.eu/meetdocs/committees/deve/20020122/com(2001)366_fr.pdf Commission des Communautés Européennes (C.C.E.) Livre vert. Protnotivoir un cadre eut opeen pour la responsabilité sociale des enterprises https://europarl. europa.eu/meetdocs/committees/deve/20020122/com(2001)366_fr.pdf" (C.C.E.) Coombs, W., Holladay, S., (2012). Managing corporate social responsibility: A communication approach (1st ed.) . : Wiley-Blackwell Coombs W. Holladay S. 2012 Managing corporate social responsibility: A communication approach (1st ed.) Wiley-Blackwell Cook, L., LaVan, H., Zilic, I.(2018). "An exploratory analysis of corporate social responsibility reporting in U.S. pharmaceutical companies". Journal of Communication Management. 22 (2), 197-211. Recuperado de https://doi.org/10.1108/JCOM-02-2017-0020 Cook L. LaVan H. Zilic I. 2018 An exploratory analysis of corporate social responsibility reporting in U.S. pharmaceutical companies Journal of Communication Management 22 2 197 211 https://doi.org/10.1108/JCOM-02-2017-0020" Crommelin, D., Stolk, P., Besancon, L., Shah, V., Midha, K., Leufkens, H.(2010). "Pharmaceutical sciences in 2020". Nature Reviews Drug Discovery. 9 , 99-100. Recuperado de https://doi.org/10.1038/nrd3087 Crommelin D. Stolk P. Besancon L. Shah V. Midha K. Leufkens H. 2010 Pharmaceutical sciences in 2020 Nature Reviews Drug Discovery 9 99 100 https://doi.org/10.1038/nrd3087" Davis, K.(1967). "Understanding the social responsibility puzzle". Business Horizons. 10 (4), 45-51. Recuperado de https://doi.org/10.1016/0007-6813(67)90007-9 Davis K. 1967 Understanding the social responsibility puzzle Business Horizons 10 4 45 51 https://doi.org/10.1016/0007-6813(67)90007-9" Demir, M., Min, M.(2019). "Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry". Sustainability Accounting. Management and Policy Journal. 10 (2), 333-364. Recuperado de https://doi.org/10.1108/SAMPJ-03-2018-0094 Demir M. Min M. 2019 Consistencies and discrepancies in corporate social responsibility reporting in the pharmaceutical industry Sustainability Accounting. Management and Policy Journal 10 2 333 364 https://doi.org/10.1108/SAMPJ-03-2018-0094" Duque, Y., Cardona, M., Rendón, J.(2013). "Responsabilidad social empresarial: Teorías, índices, estándares y certificaciones". uadernos de Administración- Universidad del Valle. 29 (50), 196-206. Recuperado de http://www.redalyc.org/articulo.oa?id=225029797009 Duque Y. Cardona M. Rendón J. 2013 Responsabilidad social empresarial: Teorías, índices, estándares y certificaciones uadernos de Administración- Universidad del Valle 29 50 196 206 http://www.redalyc.org/articulo.oa?id=225029797009" Egri, C., Ralston, D.(2008). "Corporate responsibility: A review of international management research from 1998 to 2007". Journal of International Management. 14 (4), 319-339. Recuperado de https://doi.org/10.1016/j.intman.2007.09.003 Egri C. P. Ralston D. A. 2008 Corporate responsibility: A review of international management research from 1998 to 2007 Journal of International Management 14 4 319 339 https://doi.org/10.1016/j.intman.2007.09.003" Elms, H., Berman, S., Wicks, A.(2002). "Ethics and incentives: An evaluation and development of stakeholder theory in the health care industry". Business Ethics Quarterly. 12 (4), 413-432. Recuperado de https://doi.org/10.2307/3857993 Elms H. Berman S. Wicks A. 2002 Ethics and incentives: An evaluation and development of stakeholder theory in the health care industry Business Ethics Quarterly 12 4 413 432 https://doi.org/10.2307/3857993" Emanuel, E., Wendler, D., Killen, J., Grady, C.(2004). "What makes clinical research in developing countries ethical? The benchmarks of ethical research". The Journal of Infectious Diseases. 189 (5), 930-937. Recuperado de https://doi.org/10.1086/381709 Emanuel E. J. Wendler D. Killen J. Grady C. 2004 What makes clinical research in developing countries ethical? The benchmarks of ethical research The Journal of Infectious Diseases 189 5 930 937 https://doi.org/10.1086/381709" Finegold, D., Bensimon, C., Daar, A., Eaton, M., Godard, B., Knoppers, B., Mackie, J., Singer, P., (2005). BioIndustry Ethics (1st ed.) . : Elsevier Academic Press Finegold D. L. Bensimon C. M. Daar A. S. Eaton M. L. Godard B. Knoppers B. M. Mackie J. E. Singer P. A. 2005 BioIndustry Ethics (1st ed.) Elsevier Academic Press Frederick, W.(1960). "The growing concern over business responsibility". California Management Review. 2 (4), 54-61. Recuperado de https://doi.org/10.2307%2F41165405 Frederick W. 1960 The growing concern over business responsibility California Management Review 2 4 54 61 https://doi.org/10.2307%2F41165405" Friedman, M.(1970). "The social responsibility of business is to increase its profits". The New York Times Magazine. (September), 1-6. Friedman M. 1970 The social responsibility of business is to increase its profits The New York Times Magazine September 1 6 Fort, T.(2014). "The paradox of pharmaceutical CSR: The sincerity nexus". Business Horizons. 57 (2), 151-160. Recuperado de https://doi.org/10.1016/j.bushor.2013.10.006 Fort T. 2014 The paradox of pharmaceutical CSR: The sincerity nexus Business Horizons 57 2 151 160 https://doi.org/10.1016/j.bushor.2013.10.006" Gallagher, J., Goodstein, J.(2002). "Fulfilling institutional responsibilities in health care: Organizational ethics and the role of mission discernment". Business Ethics Quarterly. 12 (4), 433-450. Recuperado de https://doi.org/10.2307/3857994 Gallagher J. A. Goodstein J. 2002 Fulfilling institutional responsibilities in health care: Organizational ethics and the role of mission discernment Business Ethics Quarterly 12 4 433 450 https://doi.org/10.2307/3857994" Gambardella, A., (1995). Science and innovation: The US pharmaceutical industry during the 1980s (1st ed.) . : Cambridge University Press Gambardella A. 1995 Science and innovation: The US pharmaceutical industry during the 1980s (1st ed.) Cambridge University Press Ghormley, E., Falconi, T. 2010. Communicating responsibility: Capstone research. prepared for NYU M.S. in PR & CC. Recuperado de https://silo.tips/download/communicatingresponsibility- capstone-research-prepared-for-nyu-ms-in-pr-cc Ghormley E. Falconi T. Communicating responsibility: Capstone research https://silo.tips/download/communicatingresponsibility- capstone-research-prepared-for-nyu-ms-in-pr-cc" prepared for NYU M.S. in PR & CC Givel, M.(2013). "Modern neoliberal philanthropy: motivations and impact of Pfizer Pharmaceutical’s corporate social responsibility campaign". Third World Quarterly. 34 (1), 171-182. Recuperado de https://doi.org/10.1080/01436597.2012.755013 Givel M. 2013 Modern neoliberal philanthropy: motivations and impact of Pfizer Pharmaceutical’s corporate social responsibility campaign Third World Quarterly 34 1 171 182 https://doi.org/10.1080/01436597.2012.755013" Goldacre, B., (2012). Bad pharma: How drug companies mislead doctors and harm patients (1st ed.) . : Fourth Estate Goldacre B. 2012 Bad pharma: How drug companies mislead doctors and harm patients (1st ed.) Fourth Estate Görpe, S., Oksuz, B. (2016). Corporate social responsibility in the Turkish pharmaceutical industry . En Örtenblad, A (autor.);Research handbook on corporate social responsibility in context. (251-269).: Edward Elgar Publishing Limited Recuperado de https://doi.org/10.4337/9781783474806 Görpe S. Oksuz B. Corporate social responsibility in the Turkish pharmaceutical industry 2016 Research handbook on corporate social responsibility in context Edward Elgar Publishing Limited 251 269 https://doi.org/10.4337/9781783474806" Görpe, S., Oksuz, B. (2016). Corporate social responsibility as concept and activity: an overview . En Örtenblad, A (autor.);Research handbook on corporate social responsibility in context. (17-31).: Edward Elgar Publishing Limited Recuperado de https://doi.org/10.4337/9781783474806 Görpe S. Oksuz B. Corporate social responsibility as concept and activity: an overview 2016 Research handbook on corporate social responsibility in context Edward Elgar Publishing Limited 17 31 https://doi.org/10.4337/9781783474806" Guthey, E., Morsing, M.(2013). "CSR and the mediated emergence of strategic ambiguity". Journal of Business Ethics. 120 (4), 555-569. Recuperado de https://doi.org/10.1007/s10551-013-2005-7 Guthey E. Morsing M. 2013 CSR and the mediated emergence of strategic ambiguity Journal of Business Ethics 120 4 555 569 https://doi.org/10.1007/s10551-013-2005-7" Hansen, S. (1982). Studies in internationalisation of the pharmaceuticals industry – A taxonomic approach (Doctoral thesis). Åbo Akademi University Hansen S. O. 1982 Studies in internationalisation of the pharmaceuticals industry – A taxonomic approach Iñesta, A., Oteo, L.(2011). "The pharmaceutical industry and the sustainability of healthcare systems in developed countries and in Latin America". Ciência & Saúde Coletiva. 16 (6), 2713-2724. Recuperado de https://doi.org/10.1590/s1413-81232011000600010 Iñesta A. Oteo L. 2011 The pharmaceutical industry and the sustainability of healthcare systems in developed countries and in Latin America Ciência & Saúde Coletiva 16 6 2713 2724 https://doi.org/10.1590/s1413-81232011000600010" International Organization for Standarization 2010. Guidance on social responsibility (ISO 26000:2010). Recuperado de https://www.iso.org/obp/ui#iso:std:iso:26000:ed-1:v1:es International Organization for Standarization Guidance on social responsibility (ISO 26000:2010) https://www.iso.org/obp/ui#iso:std:iso:26000:ed-1:v1:es" Khaleel, M., Chelliah, S., Rauf, S., Jamil, M.(2017). "Impact of perceived corporate social responsibility on attitudes and behaviors of pharmacists working in MNCs". Humanomics. 33 (4), 453-469. Recuperado de https://doi.org/10.1108/H-10-2016-0080 Khaleel M. Chelliah S. Rauf S. Jamil M. 2017 Impact of perceived corporate social responsibility on attitudes and behaviors of pharmacists working in MNCs Humanomics 33 4 453 469 https://doi.org/10.1108/H-10-2016-0080" Kolk, A.(2016). "The social responsibility of international business: From ethics and the environment to CSR and sustainable development". Journal of World Business. 51 (1), 23-34. Recuperado de https://doi.org/10.1016/j.jwb.2015.08.010 Kolk A. 2016 The social responsibility of international business: From ethics and the environment to CSR and sustainable development Journal of World Business 51 1 23 34 https://doi.org/10.1016/j.jwb.2015.08.010" Leisinger, K.(2009). "Corporate responsibilities for access to medicines". Journal of Business Ethics. 85 (S1), 3-23. Recuperado de https://doi.org/10.1007/s10551-008-9944-4 Leisinger K. M. 2009 Corporate responsibilities for access to medicines Journal of Business Ethics 85 S1 3 23 https://doi.org/10.1007/s10551-008-9944-4" Leisinger, K.(2005). "The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation". Business Ethics Quarterly. 15 (4), 577-594. Recuperado de https://doi.org/10.5840/beq200515440 Leisinger K. M. 2005 The corporate social responsibility of the pharmaceutical industry: Idealism without illusion and realism without resignation Business Ethics Quarterly 15 4 577 594 https://doi.org/10.5840/beq200515440" Mehralian, G., Nazari, J., Zarei, L., Rasekh, H.(2016). "The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM". Journal of Cleaner Production. 135 , 689-698. Recuperado de https://doi.org/10.1016/j.jclepro.2016.06.116 Mehralian G. Nazari J. Zarei L. Rasekh H. R. 2016 The effects of corporate social responsibility on organizational performance in the Iranian pharmaceutical industry: The mediating role of TQM Journal of Cleaner Production 135 689 698 https://doi.org/10.1016/j.jclepro.2016.06.116" Mögele, B., Tropp, J.(2010). "The emergence of CSR as an advertising topic: A longitudinal study of German CSR advertisements". Journal of Marketing Communications. 16 (3), 163-181. Recuperado de https://doi.org/10.1080/13527260802648359 Mögele B. Tropp J. 2010 The emergence of CSR as an advertising topic: A longitudinal study of German CSR advertisements Journal of Marketing Communications 16 3 163 181 https://doi.org/10.1080/13527260802648359" Min, M., Desmoulins-Lebeault, F., Esposito, M.(2017). "Should pharmaceutical companies engage in corporate social responsibility?". Journal of Management Development. 36 (1), 58-70. Recuperado de https://doi.org/10.1108/JMD-09-2014-0103 Min M. Desmoulins-Lebeault F. Esposito M. 2017 Should pharmaceutical companies engage in corporate social responsibility? Journal of Management Development 36 1 58 70 https://doi.org/10.1108/JMD-09-2014-0103" Nussbaum, A.(2009). "Ethical corporate social responsibility (CSR) and the pharmaceutical industry: A happy couple?". Journal of Medical Marketing. 9 (1), 67-76. Recuperado de https://doi.org/10.1057/jmm.2008.33 Nussbaum A. 2009 Ethical corporate social responsibility (CSR) and the pharmaceutical industry: A happy couple? Journal of Medical Marketing 9 1 67 76 https://doi.org/10.1057/jmm.2008.33" O’Riordan, L., Fairbrass, J.(2008). "Corporate social responsibility (CSR): Models and theories in stakeholder dialogue". Journal of Business Ethics. 83 (4), 745-758. Recuperado de https://doi.org/10.1007/s10551-008-9662-y O’Riordan L. Fairbrass J. 2008 Corporate social responsibility (CSR): Models and theories in stakeholder dialogue Journal of Business Ethics 83 4 745 758 https://doi.org/10.1007/s10551-008-9662-y" Osterath, B. sin fecha. The drug divide: Concerns grow in the US over generics produced in India. DW. Recuperado de https://www.dw.com/en/the-drug-divide-concerns-growin- the-us-over-generics-produced-in-india/a-17507784 Osterath B. The drug divide: Concerns grow in the US over generics produced in India https://www.dw.com/en/the-drug-divide-concerns-growin- the-us-over-generics-produced-in-india/a-17507784" DW Palazzo, G., Scherer, A.(2006). "Corporate legitimacy as deliberation: A communicative framework". Journal of Business Ethics. 66 (1), 71-88. Recuperado de https://doi.org/10.1007/s10551-006-9044-2 Palazzo G. Scherer A. 2006 Corporate legitimacy as deliberation: A communicative framework Journal of Business Ethics 66 1 71 88 https://doi.org/10.1007/s10551-006-9044-2" Pisano, G., (2006). Science business: The promise, the reality, and the future of biotech (1st ed.) . : Harvard Business Press Pisano G. 2006 Science business: The promise, the reality, and the future of biotech (1st ed.) Harvard Business Press Price Water House Coopers 2009. Pharma 2020: Challenging business models. Which path will you take?. PWC. Recuperado de https://www.pwc.com/gx/en/pharma-life-sciences/pdf/challenge.pdf Price Water House Coopers Pharma 2020: Challenging business models. Which path will you take? https://www.pwc.com/gx/en/pharma-life-sciences/pdf/challenge.pdf" PWC Rodríguez, P., Siegel, D., Hillman, A., Eden, L.(2006). "Three lenses on the multinational enterprise: Politics, corruption, and corporate social responsibility". Journal of International Business Studies. 37 (6), 733-746. Recuperado de https://doi.org/10.1057/palgrave.jibs.8400229 Rodríguez P. Siegel D. S. Hillman A. Eden L. 2006 Three lenses on the multinational enterprise: Politics, corruption, and corporate social responsibility Journal of International Business Studies 37 6 733 746 https://doi.org/10.1057/palgrave.jibs.8400229" Rusu, A., Kuokkanen, K., Heier, A.(2011). "Current trends in the pharmaceutical industry – A case study approach". uropean Journal of Pharmaceutical Sciences. 44 (3), 437-440. Recuperado de https://doi.org/10.1016/j.ejps.2011.07.008 Rusu A. Kuokkanen K. Heier A. 2011 Current trends in the pharmaceutical industry – A case study approach uropean Journal of Pharmaceutical Sciences 44 3 437 440 https://doi.org/10.1016/j.ejps.2011.07.008" Shamir, R.(2008). "The age of responsibilization: On market-embedded morality". Economy and Society. 37 (1), 1-19. Recuperado de https://doi.org/10.1080/03085140701760833 Shamir R. 2008 The age of responsibilization: On market-embedded morality Economy and Society 37 1 1 19 https://doi.org/10.1080/03085140701760833" Sillup, G., Makowska, M., Porth, S.(2017). "Ethical issues affecting the pharmaceutical industry-a comparison of newspaper coverage in the U.S. and Poland". Acta Poloniae Pharmaceutica - Drug Research. 74 (4), 1301-1312. Recuperado de https://www.academia.edu/download/53858784/1301.pdf Sillup G. Makowska M. Porth S. 2017 Ethical issues affecting the pharmaceutical industry-a comparison of newspaper coverage in the U.S. and Poland Acta Poloniae Pharmaceutica - Drug Research 74 4 1301 1312 https://www.academia.edu/download/53858784/1301.pdf" Strand, R., Freeman, R., Hockerts, K.(2015). "Corporate social responsibility and sustainability in Scandinavia: An overview". Journal of Business Ethics. 127 (1), 1-15. Recuperado de http://doi.org/10.1007/s10551-014-2224-6 Strand R. Freeman R. E. Hockerts K. 2015 Corporate social responsibility and sustainability in Scandinavia: An overview Journal of Business Ethics 127 1 1 15 http://doi.org/10.1007/s10551-014-2224-6" Suchanek, A., Lin-Hi, N.(2007). "Corporate responsibility in the research-based pharmaceutical industry". Jahrbucher Fur Nationalokonomie Und Statistik. 227 (5-6), 547-562. Recuperado de http://doi.org/10.1515/jbnst-2007-5-609 Suchanek A. Lin-Hi N. 2007 Corporate responsibility in the research-based pharmaceutical industry Jahrbucher Fur Nationalokonomie Und Statistik 227 5-6 547 562 http://doi.org/10.1515/jbnst-2007-5-609" Thorsteinsdóttir, H., Ovtcharenko, N., Kohler, J.(2017). "Corporate social responsibility to improve access to medicines: the case of Brazil". Globalization and Health. 13 (10), 1-12. Recuperado de http://doi.org/10.1186/s12992-017-0235-7 Thorsteinsdóttir H. Ovtcharenko N. Kohler J. C. 2017 Corporate social responsibility to improve access to medicines: the case of Brazil Globalization and Health 13 10 1 12 http://doi.org/10.1186/s12992-017-0235-7" Vanhamme, J., Grobben, B.(2009). "Too good to be true! The effectiveness of CSR history in countering negative publicity". Journal of Business Ethics. 85 (2), 273-283. Recuperado de https://doi.org/10.1007/s10551-008-9731-2 Vanhamme J. Grobben B. 2009 Too good to be true! The effectiveness of CSR history in countering negative publicity Journal of Business Ethics 85 2 273 283 https://doi.org/10.1007/s10551-008-9731-2" World Commission on Environment and Development (WCED) 1987. Our common future. The Brundtland Report. United Nations, General Assembly. Recuperado de http://worldinbalance.net/pdf/1987-brundtland.pdf World Commission on Environment and Development (WCED) Our common future. The Brundtland Report http://worldinbalance.net/pdf/1987-brundtland.pdf" United Nations, General Assembly World Health Organization 2012. Why is good governance relevant to the pharmaceutical public sector?. WHO. Recuperado de http://www.who.int/medicines/areas/policy/ goodgovernance/why/en/ World Health Organization Why is good governance relevant to the pharmaceutical public sector? http://www.who.int/medicines/areas/policy/ goodgovernance/why/en/" WHO Zhao, H., Zhangb, F., Kwonc, J.(2017). "Corporate social responsibility research in international business journals: An author co-citation analysis". International Business Review. 27 (2), 389-400. Recuperado de http://doi.org/10.1016/j.ibusrev.2017.09.006 Zhao H. Zhangb F. Kwonc J. 2017 Corporate social responsibility research in international business journals: An author co-citation analysis International Business Review 27 2 389 400 http://doi.org/10.1016/j.ibusrev.2017.09.006"